Article
microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
21 Feb 2023
Abstract excerpt
Atrial fibrillation is a complex and multifactorial disease. Although prophylactic anticoagulation has great benefits in avoiding comorbidities, adverse cardiovascular events still occur and thus in recent decades, many resources have been invested in the identification of useful markers in the prevention of the risk of MACE in these patients. As such, microRNAs, that are small non-coding RNAs whose function is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
